智通财经APP讯,普华和顺(01358)公布附属四川睿健医疗2024年业绩,收入约4.83亿元,同比增长17.63%;归属于四川睿健医疗股东的净利润约1.28亿元,同比减少12.63%。
公告称,净利下降主要由于毛利增加被一次性政府补贴减少及以股份为基础的薪酬开支增加和与分拆上市有关的中介费用增加所抵销。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.